What We're Reading: Page 102
Industry reads hand-picked by our editors
Sep 21, 2022
-
The Wall Street Journal
Asia to Roll Out First Inhaled and Nasal-Spray Covid Vaccines
-
Science
China bets big on brain research with massive cash infusion and openness to monkey studies
-
Boston Business Journal
How a local antibody maker scored its $1.75B deal with Celltrion
Sep 20, 2022
-
STAT
New CRISPR startup seeks to fix diseases caused by large DNA errors
-
Boston Business Journal
Biogen sells one Kendall Square building to Boston Properties, ends lease on another
-
FiercePharma
Manufacturing will be separator for Humira biosim challengers
-
MIT Technology Review
An AI that can design new proteins could help unlock new cures and materials
Sep 19, 2022
-
Boston Business Journal
Inside the push to bring ARPA-H to Massachusetts
-
FiercePharma
AbbVie and BMS unveil 360 total job cuts across three sites
-
Wall Street Journal
Games That Push the Brain to the Limit Get Scientists’ Attention in Fight Against Dementia
-
Science
Will the monkeypox virus become more dangerous?
Sep 16, 2022
-
The Wall Street Journal
Biotech May Be the Next U.S.-China Battleground
-
Reuters
Consumer group says drugmakers abuse U.S. patent system to keep prices high
-
MIT Technology Review
US launches trial for blood tests that promise to catch cancers earlier
-
Science
Cell-killing cancer therapy shows promise for a devastating autoimmune disorder
Sep 15, 2022
-
The New York Times
FDA’s Drug Industry Fees Fuel Concerns Over Influence
-
Politico
How four private groups used their clout to control the global Covid response — with little oversight
-
Bloomberg
Bayer Begins Search for New Chief Executive Officer
-
C&EN
US Treasury Department derails Asymchem’s acquisition of Snapdragon
Sep 14, 2022
-
The Wall Street Journal
Lack of Optimism for Alzheimer’s Trials Means There’s Little to Lose
-
The Financial Times
US criticised for rolling out Covid boosters without human trials
-
Axios
Affordability questions linger around over-the-counter birth control
-
Science
Polio is back rich countries, but it poses a far bigger threat to developing world
Sep 13, 2022
-
The New Yorker
Johnson & Johnson and a New War on Consumer Protection
-
Bloomberg
China Biotech Rout Shows Growing Pain From US Decoupling Drive
-
Endpoints News
The scientist who pioneered KRAS drugs has a new idea about making them more powerful
-
Healthcare Dive
Biden to ‘supercharge’ cancer moonshot initiative
Previous
